Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Operating Activities
Net income	$ 37,219	$ 29,824
Adjustments to reconcile net income to cash from operations:
Depreciation and amortization	45,500	41,984
Write-downs, net of recoveries	2,984	2,541
Change in deferred income taxes	1,035	(2,849)
Stock and other non-cash compensation	17,397	18,240
Unrealized foreign currency exchange loss	214	406
Change in fair value of equity investment	2,543	0
Loss from equity-accounted investments	789	209
(Gain) loss on non-cash contribution to equity-accounted investees	(733)	298
Investment in film assets	(15,405)	(22,240)
Changes in other non-cash operating assets and liabilities	(24,286)	(343)
Net cash provided by operating activities	67,257	68,070
Investing Activities
Purchase of property, plant and equipment	(5,528)	(7,367)
Investment in joint revenue sharing equipment	(31,099)	(22,710)
Acquisition of other intangible assets	(1,874)	(3,198)
Investment in equity securities	(15,153)	0
Net cash used in investing activities	(53,654)	(33,275)
Financing Activities
Increase in bank indebtedness	35,000	35,000
Repayment of bank indebtedness	(55,000)	(40,667)
Settlement of restricted share units and options	(8,589)	(2,567)
Treasury stock repurchased for future settlement of restricted share units	(1,572)	(3,597)
Repurchase of common shares, IMAX China	(2,659)	(46,452)
Taxes withheld and paid on employee stock awards vested	(508)	(1,437)
Common shares issued - stock options exercised	2,391	1,017
Issuance of subsidiary shares to non-controlling interests (net of return on capital)	1,106	7,546
Dividends paid to non-controlling interests	(4,384)	(6,934)
Credit facility amendment fees paid		(1,909)
Net cash used in financing activities	(53,372)	(60,000)
Effects of exchange rate changes on cash	727	95
Decrease in cash and cash equivalents during period	(39,042)	(25,110)
Cash and cash equivalents, beginning of period	141,590	158,725
Cash and cash equivalents, end of period	102,548	$ 133,615
IMAX China
Financing Activities
Repurchase of common shares, IMAX China	$ (19,157)